financetom
Business
financetom
/
Business
/
Signet Jewelers Misses Third-Quarter Views Amid North American Weakness, Lowers Full-Year Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Signet Jewelers Misses Third-Quarter Views Amid North American Weakness, Lowers Full-Year Outlook
Dec 5, 2024 8:46 AM

11:24 AM EST, 12/05/2024 (MT Newswires) -- Shares of Signet Jewelers ( SIG ) tumbled intraday Thursday after the jewelry store operator reported weaker-than-expected fiscal third-quarter results and lowered its full-year outlook amid soft sales in its North American market.

Revenue fell to $1.35 billion for the three-month period ended Nov. 2 from $1.39 billion a year ago and was below the $1.37 billion average analyst estimate in a FactSet survey. Same-store sales declined 0.7%, led by a 0.8% decrease in its North America segment that was partially offset by growth in international operations.

Adjusted earnings per share was $0.24, holding steady year over year. Analysts had projected $0.32. Shares of Signet Jewelers ( SIG ) fell 12% in Thursday trade.

The results were within management's expectations and reflect a nearly three-point sequential improvement in same store sales, Chief Financial and Operating Officer Joan Hilson said in a statement. "New fashion merchandise, which carries a higher transaction value, and continued recovery in engagement, combined to maintain both average transaction value and merchandise margin in a competitive environment," she said.

For fiscal 2025, Signet now expects sales between $6.74 billion and $6.81 billion on a 2% to 3% decline in same store sales. That compares with the outlook it provided in September of sales in the $6.66 billion to $7.02 billion range and for comparable sales to be down 4.5% to up 0.5%. Analysts surveyed by FactSet are projecting sales of $6.81 billion in the ongoing year.

The parent company of Zales, Jared and Kay Jewelers lowered its adjusted EPS guidance to between $9.62 and $10.08 from a prior range of $9.90 to $11.52. The average estimate on FactSet is for non-GAAP EPS of $10.36.

The updated outlook reflects "further integration challenges in Blue Nile and James Allen, leadership transition costs, and the accretive impact from the early completion of preferred shares redemption," according to Hilson.

Fourth-quarter revenue is projected to range between $2.38 billion and $2.46 billion while same store sales are expected to be flat to up 3%. Analysts are expecting $2.44 billion in sales in the current quarter.

Price: 86.83, Change: -11.90, Percent Change: -12.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
Mar 5, 2025
05:37 PM EST, 03/05/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said the US Food and Drug Administration approved a lower dosage of neffy for allergic emergencies, including anaphylaxis. The regulator approved a 1 milligram version of the nasal spray for children 4 years and up, the company said Wednesday in a statement. A 2 mg version of neffy,...
AirBoss Fourth-Quarter Adjusted Loss Narrows
AirBoss Fourth-Quarter Adjusted Loss Narrows
Mar 5, 2025
05:30 PM EST, 03/05/2025 (MT Newswires) -- AirBoss of America ( ABSSF ) on Wednesday after-trade said fourth-quarter adjusted loss narrowed. The company, which operates through two segments, Manufactured Products and Rubber Solutions, said its adjusted loss narrowed to US$1.6 million, or US$0.10 per share, from US$2.8 million, or US$1.33, in the prior-year quarter. Sales dipped slightly, to US$92 million,...
Axon Prices Upsized $1.75 Billion Debt Offering
Axon Prices Upsized $1.75 Billion Debt Offering
Mar 5, 2025
05:36 PM EST, 03/05/2025 (MT Newswires) -- Axon Enterprise ( AXON ) said Wednesday it priced an upsized $1.75 billion private offering of senior notes. The offering covers $1 billion principal amount of 6.125% of senior notes due 2030 and $750 million of 6.250% senior notes due 2033, according to the company. Axon said it intends to use the proceeds...
Insmed Insider Sold Shares Worth $1,989,797, According to a Recent SEC Filing
Insmed Insider Sold Shares Worth $1,989,797, According to a Recent SEC Filing
Mar 5, 2025
05:36 PM EST, 03/05/2025 (MT Newswires) -- William Lewis, Director, Chair and CEO, on March 03, 2025, sold 25,580 shares in Insmed ( INSM ) for $1,989,797. Following the Form 4 filing with the SEC, Lewis has control over a total of 618,610 common shares of the company, with 334,186 shares held directly and 284,424 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1104506/000162828025010590/xslF345X05/wk-form4_1741213663.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved